# The FARAPULSE ADVENT PIVOTAL Trial PFA System vs SOC Ablation for Paroxysmal Atrial Fibrillation

Study · id `cardio:ct-nct04612244` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04612244](<https://clinicaltrials.gov/study/NCT04612244>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04612244

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 706 participants.

## Technical summary

Registry record NCT04612244. Randomized; single masking; primary purpose treatment. Start 2021-03-01 (actual); primary completion 2023-05-15 (actual). Results posted on 2024-11-20.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 706 participants (enrolled count; ClinicalTrials.gov record NCT04612244, source copy `cardio:ctgov-nct04612244-2024-11-20`, retrieved 2026-10-26)
- Started: 2021-03-01 (actual) (ClinicalTrials.gov record NCT04612244, source copy `cardio:ctgov-nct04612244-2024-11-20`, retrieved 2026-10-26)
- Primary completion: 2023-05-15 (actual) (ClinicalTrials.gov record NCT04612244, source copy `cardio:ctgov-nct04612244-2024-11-20`, retrieved 2026-10-26)
- Completion: 2023-05-15 (actual) (ClinicalTrials.gov record NCT04612244, source copy `cardio:ctgov-nct04612244-2024-11-20`, retrieved 2026-10-26)
- Results first posted: 2024-11-20 (ClinicalTrials.gov record NCT04612244, source copy `cardio:ctgov-nct04612244-2024-11-20`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT04612244, source copy `cardio:ctgov-nct04612244-2024-11-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04612244-2024-11-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: The FARAPULSE ADVENT PIVOTAL Trial PFA System vs SOC Ablation for Paroxysmal Atrial Fibrillation
- Acronym: ADVENT
- Condition: Paroxysmal Atrial Fibrillation
- Intervention (Device): FARAPULSE Pulsed Field Ablation System
- Intervention (Device): RadioFrequency and Cryoballoon Ablation
- Lead sponsor: Boston Scientific Corporation
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Boston Scientific (`cardio:boston-scientific`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Pulsed Field or Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation (`cardio:pubmed-37634148`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Autonomic Effects of Pulsed Field vs Thermal Ablation for Treating Atrial Fibrillation: Subanalysis of ADVENT (`cardio:pubmed-38869507`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Pulsed Field vs Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation: Recurrent Atrial Arrhythmia Burden (`cardio:pubmed-38864538`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Comparison of cerebral safety after atrial fibrillation using pulsed field and thermal ablation: Results of the neurological assessment subgroup in the ADVENT trial (`cardio:pubmed-38823667`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 5e5681b420da9411ec07fa2603e88ef365738aca7e5349ed7058b6eb2295c298
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
